Two New Adenopeptins B and C Inhibit Sphere Formation of Pancreatic Cancer Cells

Overview

Journal J Antibiot (Tokyo)

Specialties Infectious Diseases
Pharmacology

Date 2023 Nov 24

PMID 38001285

Authors

Daisuke Tatsuda

Masahide Amemiya

Chisato Nosaka

Ryuichi Sawa

Hideyuki Muramatsu

Masayuki Igarashi

Junjiro Yoshida

Tomokazu Ohishi

Manabu Kawada

Affiliations

Soon will be listed here.

Abstract

Cancer remains one of the leading causes of death worldwide, particularly pancreatic cancer being lethal because of its aggressiveness and lack of early detection methods. A factor that contributes to malignancy are cancer stem cell-like characteristics promoted by the tumor-stromal interaction. Given that fibroblast conditioned medium (CM) promotes sphere formation of cancer cells, a cancer stem cell-like characteristic, its inhibitor could be a new anticancer agent. By exploring microbial cultures as a source, we found new compounds, namely, adenopeptins B (1) and C (2), from Acremonium sp. ESF00140. 1 and 2 selectively and potently inhibited the sphere formation of pancreatic cancer cells cultured in the fibroblast CM compared with the control medium. Oxygen consumption rate (OCR) assays showed that 1 and 2 inhibit OCR in pancreatic cancer cells. Studies of similar compounds suggested mitochondrial complex V inhibition. Therefore, results of measuring the activity of human mitochondrial complex V revealed that 1 and 2 inhibited its activity. Oligomycin A, an inhibitor of mitochondrial complex V, as well as 1 and 2, strongly inhibited the sphere formation of pancreatic cancer cells cultured in fibroblast CM. The addition of 1 and 2 to pancreatic cancer cells cultured in fibroblast CM increased reactive oxygen species (ROS) production compared with that in the control medium. In pancreatic cancer cells cultured in fibroblast CM, mitochondria significantly influence sphere formation, and targeting their function with 1 and 2 might provide a new therapeutic approach for pancreatic cancer.

References

Mizrahi J, Surana R, Valle J, Shroff R . Pancreatic cancer. Lancet. 2020; 395(10242):2008-2020. DOI: 10.1016/S0140-6736(20)30974-0. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Rossi F, Noren H, Jove R, Beljanski V, Grinnemo K . Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Res Ther. 2020; 11(1):489. PMC: 7672862. DOI: 10.1186/s13287-020-02018-6. View

Dean M, Fojo T, Bates S . Tumour stem cells and drug resistance. Nat Rev Cancer. 2005; 5(4):275-84. DOI: 10.1038/nrc1590. View

Eyler C, Rich J . Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol. 2008; 26(17):2839-45. PMC: 2739000. DOI: 10.1200/JCO.2007.15.1829. View

Jena B, Das C, Bharadwaj D, Mandal M . Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression. Biochim Biophys Acta Rev Cancer. 2020; 1874(2):188416. DOI: 10.1016/j.bbcan.2020.188416. View

Nair N, Sanchez Calle A, Zahra M, Prieto-Vila M, Oo A, Hurley L . A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment. Sci Rep. 2017; 7(1):6838. PMC: 5533745. DOI: 10.1038/s41598-017-07144-5. View

Tatsuda D, Yoshida J, Ohishi T, Kawada M . Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells. Anticancer Res. 2023; 43(6):2477-2489. DOI: 10.21873/anticanres.16415. View

Shintani Y, Abulaiti A, Kimura T, Funaki S, Nakagiri T, Inoue M . Pulmonary fibroblasts induce epithelial mesenchymal transition and some characteristics of stem cells in non-small cell lung cancer. Ann Thorac Surg. 2013; 96(2):425-33. DOI: 10.1016/j.athoracsur.2013.03.092. View

10.

Kawada M, Inoue H, Usami I, Ikeda D . Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions. Cancer Sci. 2008; 100(1):150-7. PMC: 11158197. DOI: 10.1111/j.1349-7006.2008.00996.x. View

11.

Yoshida J, Ohishi T, Abe H, Ohba S, Inoue H, Usami I . Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment. iScience. 2021; 24(12):103497. PMC: 8661540. DOI: 10.1016/j.isci.2021.103497. View

12.

Walcher L, Kistenmacher A, Suo H, Kitte R, Dluczek S, Strauss A . Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Front Immunol. 2020; 11:1280. PMC: 7426526. DOI: 10.3389/fimmu.2020.01280. View

13.

Kitamura K, Itoh H, Sakurai K, Dan S, Inoue M . Target Identification of Yaku'amide B and Its Two Distinct Activities against Mitochondrial FF-ATP Synthase. J Am Chem Soc. 2018; 140(38):12189-12199. DOI: 10.1021/jacs.8b07339. View

14.

Shchepina L, Pletjushkina O, Avetisyan A, Bakeeva L, Fetisova E, Izyumov D . Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene. 2002; 21(53):8149-57. DOI: 10.1038/sj.onc.1206053. View

15.

Tucker J, Townsend D . Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed Pharmacother. 2005; 59(7):380-7. PMC: 6361124. DOI: 10.1016/j.biopha.2005.06.005. View

16.

Kang K, Wang P, Yamabe N, Fukui M, Jay T, Zhu B . Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One. 2010; 5(4):e10296. PMC: 2858652. DOI: 10.1371/journal.pone.0010296. View

17.

Xue D, Zhou X, Qiu J . Emerging role of NRF2 in ROS-mediated tumor chemoresistance. Biomed Pharmacother. 2020; 131:110676. DOI: 10.1016/j.biopha.2020.110676. View

18.

Murphy M . How mitochondria produce reactive oxygen species. Biochem J. 2008; 417(1):1-13. PMC: 2605959. DOI: 10.1042/BJ20081386. View

19.

Sancho P, Burgos-Ramos E, Tavera A, Bou Kheir T, Jagust P, Schoenhals M . MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells. Cell Metab. 2015; 22(4):590-605. DOI: 10.1016/j.cmet.2015.08.015. View

20.

Kowaltowski A, de Souza-Pinto N, Castilho R, Vercesi A . Mitochondria and reactive oxygen species. Free Radic Biol Med. 2009; 47(4):333-43. DOI: 10.1016/j.freeradbiomed.2009.05.004. View